$278.55-$1.75 (-0.62%)
First Trust NYSE Arca Biotechnology Index Fund’s quoted price sits in the upper half of its reported 52-week range, 1.65% below the high.
Loading market information…
AMEX · UTES · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Virtus Reaves Utilities ETF’s quoted price sits in the lower half of its reported 52-week range, 10.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Virtus Reaves Utilities ETF’s forward annual dividend is $1.04 per share, paid quarterly. The forward yield is 1.36% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Fund seeks to provide total return through a combination of capital appreciation and income. The Fund invests not less than 80% of its total assets in equity securities of companies in the Utility Sector. It is an actively managed ETF and does not seek to replicate the performance of a specified passive index.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 09:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$278.55-$1.75 (-0.62%)
First Trust NYSE Arca Biotechnology Index Fund’s quoted price sits in the upper half of its reported 52-week range, 1.65% below the high.
$56.43-$0.64 (-1.11%)
FT Vest U.S. Equity Buffer ETF - January’s quoted price sits in the upper half of its reported 52-week range, 1.54% below the high.
$83.43-$1.18 (-1.39%)
Fidelity Quality Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 2.49% below the high.
$62.48-$0.62 (-0.98%)
FT Vest U.S. Equity Buffer ETF - February’s quoted price sits in the upper half of its reported 52-week range, 1.35% below the high.
$221.91+$0.17 (+0.08%)
iShares Morningstar U.S. Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 2.12% below the high.
$61.01-$0.71 (-1.15%)
FT Vest U.S. Equity Buffer ETF - July’s quoted price sits in the upper half of its reported 52-week range, 1.76% below the high.
$57.33-$0.73 (-1.25%)
FT Vest U.S. Equity Buffer ETF - August’s quoted price sits in the upper half of its reported 52-week range, 2.0% below the high.
$55.14-$0.92 (-1.64%)
Goldman Sachs S&P 500 Premium Income ETF’s quoted price sits in the upper half of its reported 52-week range, 2.82% below the high.
